Literature DB >> 19193288

Effect of free treatment and surveillance on HIV-infected persons who have tuberculosis, Taiwan, 1993-2006.

Shu Hui Tseng1, Donald Dah Shyong-Jiang, Hao Seong Hoi, Hsiu Yun Lo, Kao Pin Hwang.   

Abstract

In 1997, Taiwan made highly active antiretroviral therapy (HAART) available without cost to HIV-infected persons; in 2001, a national web-based surveillance system was implemented. Healthcare workers use the system to monitor patients' conditions and can intervene when necessary. Free HAART, coupled with the surveillance system, appears to have increased survival rates of HIV-infected persons with tuberculosis in Taiwan.

Entities:  

Mesh:

Year:  2009        PMID: 19193288      PMCID: PMC2657632          DOI: 10.3201/eid1502.081000

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Most experts believe that complete and efficient surveillance is the top priority in detecting and preventing outbreaks of emerging infectious diseases, such as tuberculosis (TB) and HIV coinfection (–) or influenza virus A (H5N1). In Taiwan, a national web-based surveillance system established in July 2001 provides complete and efficient reporting and management of persons coinfected with HIV and TB and enables healthcare workers to identify noncompliance with therapy and to intervene when necessary. After highly active antiretroviral therapy (HAART) became available free of charge in Taiwan in April 1997, the death rate for HIV-infected persons decreased from 5.7% in 1997 to 1.8% in 2006. To determine whether implementation of the national surveillance system in combination with the availability of free HAART further increased survival rates of HIV-infected persons with TB, we compared their demographic, clinical, and behavioral characteristics during 3 periods: 1) before free HAART was available (1993–1996); 2) after free HAART was available but before the surveillance system was implemented (1998–2000); and 3) after both free HAART and the surveillance system were available (2002–2006).

The Study

We obtained data on persons with HIV/AIDS and TB from the national databank at the Centers for Disease Control (CDC Taiwan) of the Department of Health, Taiwan. Coinfection with HIV and TB was defined as HIV infection in persons in whom TB was later diagnosed. A total of 660 persons with both HIV and TB were reported during 1993–2006. We used Microsoft Excel XP spreadsheet (Microsoft, Redmond, WA, USA) and SAS version 9.1 (SAS Institute Inc., Cary, NC, USA) for statistical analysis. The χ2 goodness-of-fit test with type I error = 0.05 was used to examine differences in demographic, clinical, and behavioral characteristics of persons with HIV and TB coinfection during 1993–2006. Multivariates for analysis were sex and age, results of sputum smear and sputum culture, pulmonary radiographic diagnosis, TB types (extrapulmonary and nonextrapulmonary), mode of HIV transmission, sexual behavior, compliance with HAART, and use of the surveillance system (Table 1). We used the Kaplan-Meier method () from SAS to evaluate and compare the effect on survival rates of different factors in persons coinfected with HIV and TB 1 year after reported TB diagnosis.
Table 1

Demographic and clinical characteristics of 660 persons coinfected with HIV and TB, Taiwan, 1993–2006*

CharacteristicsNo. (%) personsp value†
Sex<0.0001
M612 (92.7)
F
48 (7.3)

Age, y<0.0001
<45498 (75.5)
>45
162 (24.5)

Sputum smear (n = 484)<0.0001
Negative 287 (59.3)
Positive
197 (40.7)

Sputum culture (n = 340)0.0172
Negative 148 (43.5)
Positive
192 (56.5)

Pulmonary radiograph results (n = 531)<0.0001
Normal54 (10.2)
Abnormal
477 (89.8)

Extrapulmonary TB‡<0.0001
Yes73 (11.1)
No
587 (88.9)

Risk behavior (n = 554)<0.0001
Sexual513 (92.6)
Injection drug user
41 (7.4)

Sexual behavior (n = 566)0.0004
Heterosexual325 (57.4)
Homosexual or bisexual
241 (42.6)

Highly active antiretroviral therapy‡ (n = 534)<0.0001
1998–2006 (free)493 (92.3)
1993–1996 (not free)
41 (7.7)

National web-based surveillance reporting and management system (n = 520)<0.0001
2002–2006 (available)386 (74.2)
1998–2000 (not available)
134 (25.8)

Outcome§ (n = 606)<0.0001
Survival522 (86.1)
Death84 (13.9)

*TB, tuberculosis.
†χ2 goodness-of-fit test with type I error = 0.05 used to examine differences in demographic, clinical, and behavioral characteristics.
‡Definition following World Health Organization guideline ().
§Tracking for 1 year from report of TB diagnosis.

*TB, tuberculosis.
†χ2 goodness-of-fit test with type I error = 0.05 used to examine differences in demographic, clinical, and behavioral characteristics.
‡Definition following World Health Organization guideline ().
§Tracking for 1 year from report of TB diagnosis. Kaplan-Meier analysis yielded the following results: 63% of persons coinfected with HIV and TB survived during 1993–1996; 78% survived during 1998–2000; and 93% survived during 2002–2006 (p<0.0001) (Figure). We then applied Cox proportional hazards modeling () to each variable to assess the effect on survival rates after implementation of HAART and the surveillance system. Age <45 years, negative sputum smear, availability of free HAART, and implementation of the national surveillance system substantially increased survival rates of persons coinfected with HIV and TB (Table 2).
Figure

Kaplan-Meier analysis of survival of HIV-infected patients with tuberculosis in Taiwan during 3 different periods: before free highly active antiretroviral therapy (HAART) was available (1993–1996, black line); B) after free HAART was available but before the national web-based reporting and management surveillance system was implemented (1998–2000, red line); and C) after free HAART and the surveillance system were available (2002–2006, blue line).

Table 2

Cox regression model of possible risk factors for death among persons coinfected with HIV and tuberculosis, Taiwan, 1993–2006

Risk factorHazard ratio95% Confidence intervalp value
Sex (F)1.4620.292–7.3030.6438
Age (>45 y)2.9071.162–7.2720.0226
Sputum smear positive2.7221.008–7.3490.0482
Pulmonary radiograph abnormal7.0060.848–57.9160.0708
Pulmonary tuberculosis3.1690.641–15.6740.1573
Heterosexual2.0490.794–5.2900.1333
Before availability of free highly active antiretroviral therapy*8.3982.170–32.5080.0021
Before implementation of national web-based surveillance reporting and management system†7.6642.115–27.7680.0019

*1993–1996.
†1998–2000.

Kaplan-Meier analysis of survival of HIV-infected patients with tuberculosis in Taiwan during 3 different periods: before free highly active antiretroviral therapy (HAART) was available (1993–1996, black line); B) after free HAART was available but before the national web-based reporting and management surveillance system was implemented (1998–2000, red line); and C) after free HAART and the surveillance system were available (2002–2006, blue line). *1993–1996.
†1998–2000.

Conclusion

Many factors can increase survival rates of HIV-infected persons, such as HAART (–), prevention of opportunistic infections, patient attitude, healthcare worker knowledge, and promotion of health education. Our data indicate that national web-based surveillance reporting and management, coupled with the availability of free HAART, increase survival rates of persons coinfected with HIV and TB (p<0.0001). Taiwan’s national web-based surveillance system enables healthcare workers to follow, record, and understand the conditions of patients without geographic limitations. Physicians, public health nurses, health administrators, and other healthcare professionals in local through federal government agencies can use the system to follow up and manage the condition of persons coinfected with HIV and TB. For example, public health nurses from national healthcare centers visit such patients regularly, record treatments, and assess their conditions and compliance with therapy; staff from central health department monitor and supervise the condition of each patient through the system. In this way, the system may increase patients’ compliance and thus their survival rates (–).
  11 in total

1.  Comparison of the European Union Disease Surveillance Networks' websites.

Authors:  A Lenglet; Gloria Hernandez Pezzi
Journal:  Euro Surveill       Date:  2006

Review 2.  SmiNet-2: Description of an internet-based surveillance system for communicable diseases in Sweden.

Authors:  P Rolfhamre; A Jansson; M Arneborn; K Ekdahl
Journal:  Euro Surveill       Date:  2006

Review 3.  Tuberculosis control in the era of HIV.

Authors:  Paul Nunn; Brian Williams; Katherine Floyd; Christopher Dye; Gijs Elzinga; Mario Raviglione
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

4.  Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.

Authors:  E Girardi; F Palmieri; A Cingolani; A Ammassari; N Petrosillo; L Gillini; D Zinzi; A De Luca; A Antinori; G Ippolito
Journal:  J Acquir Immune Defic Syndr       Date:  2001-04-01       Impact factor: 3.731

5.  Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults.

Authors:  Hyun J Lim; Alphonse Okwera; Harriet Mayanja-Kizza; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  HIV Clin Trials       Date:  2006 Jul-Aug

6.  An Internet-based surveillance system for tuberculosis in Korea.

Authors:  W J Lew; E G Lee; J Y Bai; H J Kim; G H Bai; D I Ahn; J K Lee; S J Kim
Journal:  Int J Tuberc Lung Dis       Date:  2006-11       Impact factor: 2.373

7.  A national computer-based surveillance system for tuberculosis notification in Singapore.

Authors:  I Snodgrass; S K Chew
Journal:  Tuber Lung Dis       Date:  1995-06

8.  Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.

Authors:  Roberto Muga; Inmaculada Ferreros; Klaus Langohr; Patricia García de Olalla; Jorge Del Romero; Manuel Quintana; Ignacio Alastrue; Josefina Belda; Jordi Tor; Santiago Pérez-Hoyos; Julia Del Amo
Journal:  AIDS       Date:  2007-11-30       Impact factor: 4.177

9.  A computer-based surveillance system for human immunodeficiency virus infection in Singapore.

Authors:  S K Chew; I Snodgrass
Journal:  Singapore Med J       Date:  1995-04       Impact factor: 1.858

10.  Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.

Authors:  P Nunn; R Brindle; L Carpenter; J Odhiambo; K Wasunna; R Newnham; W Githui; S Gathua; M Omwega; K McAdam
Journal:  Am Rev Respir Dis       Date:  1992-10
View more
  2 in total

Review 1.  Factors that influence current tuberculosis epidemiology.

Authors:  Juan-Pablo Millet; Antonio Moreno; Laia Fina; Lucía del Baño; Angels Orcau; Patricia García de Olalla; Joan A Caylà
Journal:  Eur Spine J       Date:  2012-05-08       Impact factor: 3.134

2.  Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.

Authors:  Valeria Saraceni; Betina Durovni; Solange C Cavalcante; Silvia Cohn; Antonio Guilherme Pacheco; Lawrence H Moulton; Richard E Chaisson; Jonathan E Golub
Journal:  Braz J Infect Dis       Date:  2014-04-27       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.